Nova News
EYRIS SECURES NATIONAL SCREENING PROJECT IN SULTANATE OF OMAN
12 Dec 2023 – Nova MSC Berhad (“Nova MSC” or “the Company”), the parent company of EyRIS Pte Ltd (“EyRIS”), proudly announces that its state-of-the-art Artificial Intelligence (“AI”) tool, SELENA+, has been selected for the Sultanate of Oman’s National Diabetic Retinopathy (DR) Screening Program. This significant step underscores the global recognition and trust in EyRIS’s AI-driven solutions for enhancing healthcare…
SELENA+ USED AS TEACHING CASE FOR BUSINESS STUDENTS & CORPORATES WORLDWIDE
29 Nov 2023 – The development of SELENA+ is now used as a business teaching case about how a locally-developed eye screening artificial intelligence (AI) system from inception to commercialisation by the start-up EyRIS. The complete journey is documented by a Singapore Management University (SMU) team led by Professor Emeritus of Information Systems Steven Miller, the case is being distributed…
NOVA MSC PASSES ISO 9001:2015 RE-CERTIFICATION
5 Nov 2023 – Last week, Nova MSC received the physical copy of our ISO 9001:2015 re-certificate for the “Provision in design, development, implementation and maintenance of e-business solutions”. In the projects audited by Bureau Veritas, our team has demonstrated disciplined adherence to processes stipulated in our quality management system with ZERO non-compliances in our processes and one minor non-conformity…
EYRIS ANNOUNCES PARTNERSHIP IN QATAR
15 Oct 2023 – EyRIS is thrilled to unveil a groundbreaking partnership with Mekdam Technology, one of Qatar’s premier technology conglomerates. This partnership introduces cutting-edge AI screening tools to accelerate early detection of medical conditions. The first AI to be introduced is SELENA+ which uncover eye diseases namely diabetic retinopathy, glaucoma and age-related macular degeneration. Additional AI algorithms will follow…
EYRIS APPOINTS PARTNER IN MYANMAR
16 Oct 2023 – EyRIS is thrilled to announce a couple of partnerships in Yangon and Singapore to bring cutting-edge AI technology to Myanmar. In the near future, the cities of Yangon and Mandalay will witness the deployment of EyRIS’ state-of-the-art fully autonomous fundus camera, seamlessly integrated with our AI capabilities. This dynamic partnership is set to transform the landscape…
THETA EDGE AND NOVA FORMS JOINT VENTURE COMPANY
5 Sep 2023 – Nova has signed a landmark agreement with Theta Edge Berhad to establish a joint venture company to jointly market and implement state-of-the-art e-government solutions as well as a full range of IT services including system integration, consultancy and infrastructure system services in Malaysia. Nova MSC’s Executive Director, Mr Nazerollnizam Bin Kasim, said: “We are immensely proud…
EYRIS SELENA+ APPROVED FOR USE IN AUSTRALIA
21 Aug 2023 – We are thrilled to share that EyRIS has achieved a significant milestone by receiving TGA (Therapeutic Goods Administration) approval for the use of SELENA+ in Australia. This achievement underscores our commitment to detect retinal diseases and ultimately eliminate preventable blindness through early treatment on a global scale. A pivotal aspect of this achievement is our strategic…
NOVA USHERS IN TRANSFORMATIVE GROWTH STRATEGY WITH APPOINTMENT OF TWO NEW BOARD MEMBERS
26 Jun 2023 – Nova MSC Berhad (“NovaMSC” or “the Group”), a leading provider of software development and engineering solutions, is pleased to announce the appointment of Dato’ Adriana Law (below left) and Nazerollnizam Kasim (below right) as members of its Board of Directors. NovaMSC’s Executive Chairman, Mr Loh Guan Huat Sunny, warmly welcomed the new directors and said, “We…
EYRIS FORMS TRI-PARTITE PARTNERSHIP TO BRING SELENA+ TO TANZANIA
7 June 2023 – EyRIS is thrilled to be selected to participate in a ground-breaking tripartite partnership with The International Centre for Eye Health at the London School of Hygiene and Tropical Medicine, University of London and Tanzanian Ministry of Health. This collaboration aims to validate the use of Artificial Intelligence in screening for diabetic retinopathy (DR) in low-resource settings….
SAO RAFAEL HOSPITAL, BRAZIL POWERS SCREENING USING AI TECHNOLOGY
5 June 2023 – EyRIS is thrilled to announce our collaboration with Sao Rafael Hospital which is part of the renowned Rede D’Or São Luiz healthcare network in Brazil. This partnership underlines Rede D’Or São Luiz’s determination in improving patient care through state-of-the-art AI technology. By leveraging on SELENA+’s proven algorithms, Rede D’Or São Luiz aims to expand screening and…
SELENA+ IN ANOTHER COMMUNITY OUTREACH PROGRAM
2 June 2023 – EyRIS participated in another community outreach program, this time jointly organized by the Singapore Buddhist Youth Mission Temple and Diabetes Singapore, under the tagline “Healthiness is a Blessing”, aptly on Vesak Day. Worshippers were given the opportunity health check and experince EyRIS latest seamless workflow, which captures the fundus image and return the SELENA+ results of…
EYRIS AND OPTOMETRIST WAREHOUSE JOIN FORCES TO ADVANCE HEALTHCARE WITH AI-DRIVEN DIABETIC RETINOPATHY SCREENING
1 June 2023 – EyRIS, a pioneering company in artificial intelligence (AI) healthcare solutions, and Optometrist Warehouse, part of the Chemist Warehouse Group in Australia, have signed a Memorandum of Understanding (MOU) to collaborate on a ground-breaking study focused on the effectiveness of AI in screening diabetic retinopathy. This collaboration marks a significant milestone in the field of healthcare, showcasing…